Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.nejm.org › doi › fullTeprotumumab for the Treatment of Active Thyroid Eye Disease

   www.nejm.org › doi › full

   22 sty 2020 · Active thyroid eye disease remains an inadequately treated, life-altering, and potentially sight-threatening disease for which no FDA-approved pharmacotherapy is available.

2. www.fda.gov › fda-approves-first-treatment-thyroid-eye-diseaseFDA approves first treatment for thyroid eye disease | FDA

   www.fda.gov › fda-approves-first-treatment-thyroid-eye-disease

   • Zapisane w pamięci cache

   Today, the U.S. Food and Drug Administration (FDA) approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease, a rare condition where the muscles and fatty...

3. www.ncbi.nlm.nih.gov › pmc › articlesManagement of thyroid eye disease: a Consensus Statement by the...

   www.ncbi.nlm.nih.gov › pmc › articles

   12 gru 2022 · Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinologists.

4. www.ncbi.nlm.nih.gov › pmc › articlesUpdates on the understanding and management of thyroid eye...

   www.ncbi.nlm.nih.gov › pmc › articles

   30 cze 2021 · Thyroid eye disease (TED) is a complex disease associated with myriad clinical presentations, including facial disfigurement, vision loss, and decreased quality of life. Traditionally, steroid therapy and/or radiation therapy were commonly used in the treatment of active TED.

5. www.ncbi.nlm.nih.gov › pmc › articlesThyroid Eye Disease: Navigating the New Treatment Landscape

   www.ncbi.nlm.nih.gov › pmc › articles

   1 maj 2021 · Mild Active Thyroid Eye Disease. Supportive treatment is the mainstay in mild disease. This involves the maintenance of euthyroidism, strict tobacco avoidance, eye lubrication with drops or ointments, and selenium.

6. www.nature.com › articles › s41433/024/02967-9The changing landscape of thyroid eye disease: current clinical...

   www.nature.com › articles › s41433/024/02967-9

   19 lut 2024 · This review aims to provide an overview of the current understanding of TED and its pathophysiology. To describe the evidence base for current consensus treatment recommendations and newer ...

7. www.aao.org › eye-health › newsNew Drug Treats Thyroid Eye Disease Without Surgery

   www.aao.org › eye-health › news

   • Zapisane w pamięci cache

   5 lut 2020 · Tepezza was approved in January 2020 as the first nonsurgical treatment for thyroid eye disease (TED), a condition that causes eye bulging and vision problems. The new drug is delivered through an IV and accomplishes what surgery often cannot, experts say.